The Rajiv Gandhi Centre for Biotechnology (RGCB) had its humble beginning on July 03, 1990, as Centre for Development of Education, Science and Technology (C-DEST), an autonomous society registered under the Travancore Cochin Literary, Scientific and Charitable Society Registration Act of 1955 (Reg.No.418/90) by a group of well-known professionals and social workers for undertaking and promoting research, field studies, action projects, etc., The then Prime Minister Shri Rajiv Gandhi had kindly consented to be Chief Patron of the C-DEST Society.

It was of great credit to the institute that it was given responsibility by the Central Government for grading standards of higher education institutions, colleges and universities in the country, an accreditation system to be administered through National Accreditation Board for Higher Education (NABHE), in the year 1990. The Government of Kerala took the landmark decision to restructure the institute into a comprehensive biotechnology centre and thus was established the Rajiv Gandhi Centre for Biotechnology (RGCB) on April 18, 1994. RGCB was the first research institute established for research and development in the field of Biotechnology, in India.

Our planning for the development of RGCB comprises a set specific Strategic Goals. Through inclusive strategic planning processes, RGCB has identified these Themes and Strategic Goals as priority areas for the field. The Themes are a more general description of the areas within the field of disease biology that RGCB recognizes as important domains for targeted efforts involved in the institutes mandate, mission and vision. These Themes will allow the development of Strategic Goals, which are the specific target areas identified as priorities by RGCB. As implementation of the Strategic Plan goes forward, these Goals will be the actual areas of focus, activities, and resources. Some of these priority Strategic Goals will represent current strengths of RGCB while for others, the Institute will identify new directions for the field that will answer novel questions and require state of the art capabilities.

Strategic Goal 1: Fundamental Research - Understanding the biology that defines basic mechanisms involved in the disease process and its implications for human health
'Fundamental research' investigates the basic biological processes of how our bodies function and of the pathways and systems that are susceptible to the effects disease. This research addresses all levels of biological organization including molecular, biochemical pathway, cellular, tissue, organ, model organism, human, and population -- and builds on the knowledge from new tools and techniques that allow us to ask more in-depth questions about the effects on and response to disease in biological systems.
Strategic Goal 2: Technology Development - Turning research into technology innovation and on to business
The links between innovation, productivity, health and wealth are recognised by many countries and the need to encourage innovation is also apparent. Investing in and encouraging innovation is a priority for many jurisdictions as is the affordability, quality and sustainability of healthcare systems. Technology development theme will in addition to doing innovative research for technology development, identify present, new and unfulfilled research and technological needs; conduct peer reviews and program reviews of relevant programs for government agencies and industrial organizations and identify emerging and future technical areas including evolving multidisciplinary areas, where RGCB could be a major player
Strategic Goal 3: Translational Science - Trans-disciplinary health science to inform individual, clinical, and public health decision making to improve health
Research that moves a basic science observation into a public health or medical application is often termed 'Translational Science'. Translational Science is Theme 3, in recognition of the fact that our research priorities must include this kind of applied, outcome-oriented research for us to ensure that the full benefit of all of our research investments can be realized as part of public health, medical, regulatory, and individual practice.
Strategic Goal 4: Training and Education - Developing and retaining a sustainable pipeline of biotechnology professionals across a range of related disciplines including fundamental science, technology development, translation, policy and outreach through efforts in education, training, and career development.
Strategic Goal 5: Communications, IPR and Engagement
Advancing translation and dissemination of scientific knowledge on the role of disease and human health; pursuing appropriate and effective means of engagement of the broad range of institute stakeholders and the public in health research and public health promotion.

https://rgcb.res.in/faculty/

https://rgcb.res.in/young-investigator-awards.php

NA